Mukdahan International Hospital Public Company Limited (HANN) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Mukdahan International Hospital Public Company Limited THB 0.67, price THB 0.79, upside -15.2%, quality 61 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Mukdahan International Hospital Public Company Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Sep 24, 2026.
How to read this chart
10‑month range 0.7800 THB – 1.16 THB · fair‑value band 0.5000 THB – 0.8300 THB · the 0.7900 THB price screens above the 0.6700 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Sep 24, 2026.
Follow Mukdahan International Hospital Public Company in your weekly email
Every Wednesday you see whether Mukdahan International Hospital Public Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Mukdahan International Hospital Public Company Limited operates hospitals in Thailand. The company operates Mukdahan International Hospital, Ruampat Yasothon Hospital, and Dr. Han Hospital.
Show more
Mukdahan International Hospital Public Company Limited operates hospitals in Thailand. The company operates Mukdahan International Hospital, Ruampat Yasothon Hospital, and Dr. Han Hospital. Its clinics and treatment centers include a physical therapy center, obstetrics and gynecology clinic, urology, pediatric clinic, accident and emergency center, family medicine clinic, general practice clinic, heart specialist clinic, and kidney center. The company also offers medical technology products, such as high-power laser therapy device; peripheral magnetic stimulation; and Fisioline Radiant, a radio frequency therapy device. In addition, it provides health checkup packages and programs comprising influenza vaccine, shingles vaccine, AVF/AVG prepaid package, hepatitis B vaccine package, Baby Love vaccine packages II and III, dengue vaccine package, endoscopy package, and pre-pregnancy health checkup program, as well as vaccine package to prevent hand, foot, and mouth disease. Further, the company is involved in hospital room sales; and medicine and medical supplies sales. Mukdahan International Hospital Public Company Limited was incorporated in 1995 and is headquartered in Mukdahan, Thailand.
Stock analysis
Mukdahan International Hospital Public Company Limited (HANN) currently trades at 0.7900 THB, while our model-based Fair Value estimate is 0.6700 THB, implying the stock looks roughly 17.9% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 1.04 THB per share, and 9 of the 22 models we run sit above the 0.7900 THB price.
Bear case: the Earnings-Based group reads lowest at 0.3300 THB, and 13 of the 22 models stay below the price. Evidence for this calculation is low.
Scenario range: 0.5000 THB (bear) to 0.8300 THB (bull), the price of 0.7900 THB sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 61/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Mukdahan International Hospital Public Company Limited reported revenue of 463M THB in FY2025 versus 527M THB in FY2023, a compound −6.3%/yr. Reported net income was 22.0M THB in FY2025, compounding −11.1%/yr from FY2023.
Key figures
Market cap 493M THB (≈ $14.8M) · P/E ratio 79.0 · P/S ratio 3.75 · EPS (TTM) 0.0100 THB · Dividend yield 3.2% · Net margin 4.7% · Return on equity 1.5% · Return on assets (EBIT) 8.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −15%, HANN screens richer than that median.
Fair Value models
Bear 0.5000 THBFair Value 0.6700 THBBull 0.8300 THB
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0073 THB per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+0.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Thailand: IMF forecast 1.2% a year to 2030, 1.1% from 2016 to 2025) that is about −1.2% a year for the price.
Compare Mukdahan International Hospital Public Company Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 258 stocks
Beats the industry median on 5/14 measures
Overall it trails its industry peers.
Valuation
Quality Score61 · Above median
Fair Value upside−16% · Below median
Profitability
Return on equity (TTM)1% · Below median
Return on assets2% · Below median
Net margin (TTM)1% · Below median
Operating margin (TTM)2% · Bottom 25%
Growth and dividend
Revenue growth−9% · Bottom 25%
Dividend yield (TTM)3.2% · Above median
Balance sheet
Debt / equity0.08× · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Mukdahan International Hospital Public Company Limited Fair Value". https://www.fairvalue-calculator.com/stock/HANN
Frequently asked questions
Is Mukdahan International Hospital Public Company Limited (HANN) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 0.6700 THB versus a price of 0.7900 THB, about −15% upside (overvalued).
What is the fair value of HANN?
Our model-based fair value for Mukdahan International Hospital Public Company Limited is 0.6700 THB (as of Sep 24, 2026), built from audited fundamentals. The current price: 0.7900 THB.
What is the quality score of HANN?
Mukdahan International Hospital Public Company Limited has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mukdahan International Hospital Public Company Limited (HANN)?
Our model-based price target is the fair value of 0.6700 THB (as of Sep 24, 2026) from 22 valuation models. Cautious scenario 0.5000 THB, optimistic scenario 0.8300 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the Mukdahan International Hospital Public Company Limited stock forecast for 2026?
Our models put fair value at 0.6700 THB, about −15% upside versus a price of 0.7900 THB (overvalued). Cautious scenario 0.5000 THB, optimistic scenario 0.8300 THB. The calculation is refreshed regularly with new filings.
What is the revenue of Mukdahan International Hospital Public Company Limited (HANN)?
Mukdahan International Hospital Public Company Limited reported trailing-twelve-month revenue of about 452M THB (latest available figure, as of Sep 24, 2026).
Does Mukdahan International Hospital Public Company Limited pay a dividend?
Mukdahan International Hospital Public Company Limited currently shows a dividend yield of about 3.25% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Mukdahan International Hospital Public Company Limited (HANN)?
For today's price to be fair in a discounted-cash-flow model, Mukdahan International Hospital Public Company Limited would have to grow free cash flow by +0.0 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew -6.3 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of HANN use?
Our models discount Mukdahan International Hospital Public Company Limited at 11.6 %: a base by market capitalisation (nano), country premium for Thailand. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Mukdahan International Hospital Public Company Limited that is +0.0 % per year a year over ten years, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Mukdahan International Hospital Public Company Limited (HANN) delivered so far?
Over the past 2 years revenue at Mukdahan International Hospital Public Company Limited grew -6.3 % a year. The price currently implies +0.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Mukdahan International Hospital Public Company Limited (HANN) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into Mukdahan International Hospital Public Company Limited (+0.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Mukdahan International Hospital Public Company Limited (HANN)?
The free-cash-flow yield on the price is 8.69 %: that much free cash flow Mukdahan International Hospital Public Company Limited produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Mukdahan International Hospital Public Company Limited (HANN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mukdahan International Hospital Public Company Limited it is 0.6700 THB per share (as of Sep 24, 2026), against a price of 0.7900 THB. It is the blended result of 22 valuation models (cash flow, earnings, asset, dividend).
Is Mukdahan International Hospital Public Company Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, HANN trades above its calculated fair value: price 0.7900 THB, fair value 0.6700 THB, a gap of about −15% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HANN?
No. The price is what the market pays today (0.7900 THB); the fair value is what the company's own numbers justify (0.6700 THB). For Mukdahan International Hospital Public Company Limited the two are 0.1200 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is Mukdahan International Hospital Public Company Limited worth?
The market values Mukdahan International Hospital Public Company Limited at about 493M THB (market capitalisation, as of Sep 24, 2026). Per share that is 0.7900 THB; our models calculate a fair value of 0.6700 THB per share.
What do the bullish and bearish scenarios say about HANN?
Our models span a range for Mukdahan International Hospital Public Company Limited: cautious scenario 0.5000 THB, base 0.6700 THB, optimistic 0.8300 THB per share (as of Sep 24, 2026, price 0.7900 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of HANN?
Mukdahan International Hospital Public Company Limited trades at a price-to-earnings ratio of 79.0 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.6700 THB is built from several models across several years. Other multiples: P/B 1.6, P/S 1.1, EV/EBITDA 11.9.
How solid is the balance sheet of Mukdahan International Hospital Public Company Limited (HANN)?
Balance-sheet figures for Mukdahan International Hospital Public Company Limited (as of Sep 24, 2026): return on equity 1.5%, debt of 0.08 per unit of equity. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
Which stocks are comparable to Mukdahan International Hospital Public Company Limited?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mukdahan International Hospital Public Company Limited stock attractive at the current price?
The data as of Sep 24, 2026: price 0.7900 THB, calculated fair value 0.6700 THB (−15%), Quality Score 61/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HANN calculated?
We run Mukdahan International Hospital Public Company Limited through 22 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.6700 THB, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Mukdahan International Hospital Public Company Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mukdahan International Hospital Public Company Limited (HANN)?
The closing price on Sep 24, 2026 was 0.7900 THB. Our model-based fair value is 0.6700 THB, about −15% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mukdahan International Hospital Public Company Limited right now?
Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Mukdahan International Hospital Public Company Limited
How large is the market capitalisation of Mukdahan International Hospital Public Company Limited (HANN)?
The market capitalisation of Mukdahan International Hospital Public Company Limited is 493M THB (≈ $14.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Mukdahan International Hospital Public Company Limited (HANN)?
The price-to-sales ratio of Mukdahan International Hospital Public Company Limited is 3.75 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Mukdahan International Hospital Public Company Limited (HANN)?
Earnings per share at Mukdahan International Hospital Public Company Limited are 0.0100 THB (price ÷ EPS = P/E 79.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Mukdahan International Hospital Public Company Limited (HANN)?
The dividend yield of Mukdahan International Hospital Public Company Limited is 3.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Mukdahan International Hospital Public Company Limited (HANN)?
The net margin of Mukdahan International Hospital Public Company Limited is 4.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Mukdahan International Hospital Public Company Limited (HANN)?
The return on equity (ROE) of Mukdahan International Hospital Public Company Limited is 1.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mukdahan International Hospital Public Company Limited (HANN)?
On an EBIT basis the return on assets of Mukdahan International Hospital Public Company Limited is 8.5% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mukdahan International Hospital Public Company Limited (HANN)?
The operating margin of Mukdahan International Hospital Public Company Limited is 2.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mukdahan International Hospital Public Company Limited (HANN)?
Revenue at Mukdahan International Hospital Public Company Limited is growing −9.3% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Mukdahan International Hospital Public Company Limited (HANN)?
Earnings per share at Mukdahan International Hospital Public Company Limited are growing −93.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Mukdahan International Hospital Public Company Limited (HANN) carry?
The net debt of Mukdahan International Hospital Public Company Limited is 50.8M THB (fiscal year 2024, ≈ 1.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Mukdahan International Hospital Public Company Limited in the live analysis
One click puts Mukdahan International Hospital Public Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
